Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57K Buy
25
+7
+39% +$489 ﹤0.01% 405
2026
Q1
$1.36K Buy
+18
New +$1.28K ﹤0.01% 410
2025
Q2
Sell
-76
Closed -$3.77K 495
2025
Q1
$3.77K Hold
76
﹤0.01% 205
2024
Q4
$3.4K Hold
76
﹤0.01% 200
2024
Q3
$3.65K Buy
+76
New +$3.66K ﹤0.01% 194

Other funds holding NTR

Swan Capital's NTR Position: Q2 2026 in Review

Swan Capital increased its Nutrien (NTR) stake by 39% in Q2 2026, buying an estimated $489 and bringing the position to 25 shares worth $1.57K. The position accounts for ﹤0.01% of the portfolio, ranked #405.

Swan Capital first reported a position in NTR in Q3 2024 and has held it in 5 quarters since. The position peaked at $3.77K in Q1 2025. 731 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Swan Capital held 25 shares of Nutrien worth $1.57K as of Q2 2026.
  • Swan Capital bought 7 Nutrien shares in Q2 2026, an estimated $489.
  • Nutrien made up ﹤0.01% of Swan Capital's portfolio in Q2 2026, its #405 holding.
  • Swan Capital first reported a position in Nutrien in Q3 2024 and has held it in 5 quarters since.
  • Swan Capital's Nutrien position peaked at $3.77K in Q1 2025.
  • 731 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Swan Capital's 13F filing for Q2 2026, filed 13 Aug 2026.